KEY FEATURES
Full Name | Cluster Of Differentiation 55 |
---|---|
Synonym | DAF; CR; TC; Complement decay-accelerating factor; Decay Accelerating Factor |
Assay Type | Sandwich |
Reactivity | Human |
Range | 3.12-200ng/mL |
Sensitivity | 1.13ng/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human CD55 in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human CD55. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human CD55 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human CD55, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human CD55. You can calculate the concentration of Human CD55 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human CD55 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (ng/mL) | 9.33 | 26.06 | 71.06 | 10.11 | 26.14 | 69.73 |
Standard deviation | 0.56 | 1.5 | 2.66 | 0.68 | 1.33 | 2.71 |
CV(%) | 6 | 5.75 | 3.74 | 6.69 | 5.07 | 3.89 |
RECOVERY
The recovery of Human CD55 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 87-102 | 93 |
EDTA plasma (n=8) | 90-104 | 97 |
Cell culture media (n=8) | 91-103 | 97 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human CD55 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with DAF ELISA Kits
CD59 ELISA Kit | publications with DAF and CD59 |
CD97 ELISA Kit | publications with DAF and CD97 |
ICAM1 ELISA Kit | publications with DAF and ICAM1 |
PIGA ELISA Kit | publications with DAF and PIGA |
EMR2 ELISA Kit | publications with DAF and EMR2 |
FYN ELISA Kit | publications with DAF and FYN |
VEGFA ELISA Kit | publications with DAF and VEGFA |
CD1D ELISA Kit | publications with DAF and CD1D |
Pathways associated with DAF ELISA Kit
Class B/2 (Secretin Family Receptors) Pathway | Class B/2 (Secretin Family Receptors) Pathway |
Complement Activation, Classical Pathway | Complement Activation, Classical Pathway |
Complement And Coagulation Cascades Pathway | Complement And Coagulation Cascades Pathway |
Complement Cascade Pathway | Complement Cascade Pathway |
Defective ACTH Causes Obesity And Pro-opiomelanocortinin Deficiency (POMCD) Pathway | Defective ACTH Causes Obesity And Pro-opiomelanocortinin Deficiency (POMCD) Pathway |
Disease Pathway | Disease Pathway |
GPCR Ligand Binding Pathway | GPCR Ligand Binding Pathway |
Hematopoietic Cell Lineage Pathway | Hematopoietic Cell Lineage Pathway |
Diseases associated with DAF ELISA Kit
Anemia | publications with DAF and Anemia |
Inflammation | publications with DAF and Inflammation |
Carcinoma | publications with DAF and Carcinoma |
Necrosis | publications with DAF and Necrosis |
Disease Models, Animal | publications with DAF and Disease Models, Animal |
Kidney Diseases | publications with DAF and Kidney Diseases |
Nervous System Diseases | publications with DAF and Nervous System Diseases |
Lung Diseases | publications with DAF and Lung Diseases |
Breast Neoplasms | publications with DAF and Breast Neoplasms |
Heart Diseases | publications with DAF and Heart Diseases |
Organs/Tissues associated with DAF ELISA Kit
Blood | publications with DAF and Blood |
Vascular | publications with DAF and Vascular |
Kidney | publications with DAF and Kidney |
Bone | publications with DAF and Bone |
Heart | publications with DAF and Heart |
Bone Marrow | publications with DAF and Bone Marrow |
Muscle | publications with DAF and Muscle |
Lung | publications with DAF and Lung |
Liver | publications with DAF and Liver |
Ovary | publications with DAF and Ovary |